Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2021-05-10
Product name
Pradaxa capsules
Product Synonyms
Pradaxa® Capsules 50 mg, 75 mg, 110 mg and 150 mg
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ing. Pharmaceuticals, Inc
Emergency telephone
+1 703-527-3887
Icons in SDS
Company Information
company name
Boehringer Ing. Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR 1910.1200) Serious eye damage Category 1
Signal word
Danger
Hazard statements
H318 Causes serious eye damage.
Prevention
P280 Wear eye protection/ face protection.
Response
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
